Mot de passe
Afficher le mot de passe
Mot de passe oublié ?
Devenir membre gratuitement
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Cotations dynamiques 


SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur DAIICHI SANKYO COMPANY, LIMITED
18/10Nikkei 225 Edges Down 0.2% on Profit-Taking, Energy Outlook
13/10DEFENCE THERAPEUTICS INC. : Bei einer In Vitro-Studie erhöhen eie Accumtm-Varianten von De..
13/10Bei einer in vitro-studie erhöhen die accum(tm)-varianten von defence therapeutics die ..
12/10DAIICHI SANKYO : Corporate Governance Report
05/10DAIICHI SANKYO : Astrazeneca - Enhertu granted Breakthrough Therapy Designation in US for ..
04/10Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca Receive Gra..
04/10FDA gibt Astrazeneca-Krebsmittel Enhertu Status als Durchbruchtherapie
04/10ASTRAZENECA : Daiichi Sankyo's Enhertu Gets US FDA Breakthrough Therapy Tag for Breast Can..
04/10AstraZeneca Says FDA Granted Breakthrough-Therapy Designation for Cancer Treatment Enhe..
21/09Nikkei 225 Falls 2.2% on China Property Outlook
21/09Japanese shares fall on Evergrande jitters; bargain-hunting limits losses
20/09DAIICHI SANKYO : Enhertu reduced the risk of disease progression or death by 72% vs. trast..
20/09DAIICHI SANKYO : Enhertu demonstrated robust and durable tumour response of 54.9% in patie..
20/09ASTRAZENECA : Touts Positive Survival Data for Cancer Therapies Imfinzi, Enhertu
20/09DAIICHI SANKYO : Enhertu demonstrated clinically meaningful and durable response in patien..
20/09ASTRAZENECA : Daiichi Sankyo's Enhertu Reduces Breast Cancer Death In Late-Stage Study
20/09ASTRAZENECA : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patien..
20/09ASTRAZENECA : Daiichi Sankyo's Enhertu Prolongs Survival in Mid-Stage Gastric Cancer Study
18/09DAIICHI SANKYO : ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus T..
18/09Daiichi Sankyo Company, Limited and AstraZeneca Announce Reduction of Risk of Disease P..
18/09Daiichi Sankyo Company Demonstrated Robust and Durable Tumor Response of 54.9% in Patie..
18/09Daiichi Sankyo Company, Limited and AstraZeneca announce ENHERTU® Demonstrated Clinical..
17/09AstraZeneca Sees Positive Results for Enhertu Trial
17/09Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute, LLC Announce DS-73..
17/09Japanese shares edge up as FOMO keeps rally alive
16/09DPA-AFX ÜBERBLICK : KONJUNKTUR vom 16.09.2021 - 17.00 Uhr
16/09IAEA hebt erstmals seit Fukushima Prognose für Atomenergie an
16/09Daiichi Sankyo Company, Limited and AstraZeneca Announces That the First Patient Was Do..
16/09China's biotech sector comes of age with big licensing deals, global ambitions
13/09DEFENCE THERAPEUTICS INC. : Health Europa berichtet über Defence Therapeutics: Die Accum-T..
07/09URAVAN MINERALS : Rises 20% as it Looks at Strategic Alternatives Because of Low Uranium P..
30/08Daiichi Sankyo Company, Limited Announces Results from the Multinational, Randomized, C..
20/08NIKKEI 225 : Declines 1% On Toyota, Pandemic Outlooks
20/08Nikkei falls to 8-month low as Toyota drags peers, materials makers
20/08Nikkei slides to 7-month low as Toyota drags peers, other cyclicals
19/08Defence therapeutics selects the best 8 accumtm variants to optimize its adc therapeuti..
19/08Toyota drags Nikkei to 7-month low after output cut report
19/08Japanese shares fall, struggle to shake off Delta variant fears
18/08IRW-PRESS : Defence Therapeutics Inc.: Defence Therapeutics wählt die besten 8 Accum(TM)-V..
18/08PRESS RELEASE : Defence therapeutics selects the best 8 accum(tm) variants to optimize its..
17/08NIKKEI 225 : Down 0.4% as Pandemic Undercuts Optimism
12/08Interim Results for the Six Months Ended 30 June -2-
10/08LOGICBIO THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Highlights Recen..
10/08DAIICHI SANKYO : Enhertu significantly improved progression-free survival in DESTINY-Breas..
09/08ENHERTU® (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Progression-Free Surv..
09/08ASTRAZENECA : Forxiga Nabs New EU Nod As Enhertu Logs Breast Cancer Win
09/08ASTRAZENECA : Breast Cancer Drug Shown to Extend Lives Better Than Roche's Kadcyla in Phas..
09/08DAIICHI SANKYO : ENHERTU® Significantly Improved Progression-Free Survival in DESTINY-Brea..
30/07MÄRKTE ASIEN/Schwach - Corona-Sorgen in Tokio nehmen zu
30/07MÄRKTE ASIEN/Schwächer - Fanuc und Fujitsu nach Zahlen sehr schwach
30/07DAIICHI SANKYO : Top Management Presentation
30/07DAIICHI SANKYO : Consolidated Financial Results for the First Three Months of the Year End..
30/07DAIICHI SANKYO : Reference Data
30/07Daiichi Sankyo Company, Limited Provides Dividend Guidance for the Year Ending March 31..
30/07Daiichi Sankyo Company, Limited Forecasts Dividend for the Second Quarter of Fiscal Yea..
30/07Daiichi Sankyo Company, Limited Provides Earnings Guidance for the Full Year Ending Mar..
30/07Daiichi Sankyo Company, Limited Reports Consolidated Earnings Results for the First Qua..
21/07Daiichi Sankyo Completes Issue of Shares in Stock Compensation Program
08/07ASTRAZENECA : Daiichi Sankyo, AstraZeneca's Late-Stage Trial of Enhertu for Gastric Cancer..
08/07ASTRAZENECA : Daiichi Sankyo Late-Stage Trial of Enhertu for Gastric Cancer Doses First Pa..
08/07Daiichi Sankyo Company, Limited and AstraZeneca Announces DESTINY-Gastric04 Head-to-Hea..
02/07Nikkei ends higher on Sony, Toyota boost; posts weekly drop on virus woes
01/07TOKYO ELECTRIC POWER INCORPORATED : Olympics-Japan PM says no spectators possible as Samoa..
23/06Chiude piatta, guadagni nei chip bilanciano perdite case farmaceutiche
23/06Daiichi Sankyo to Issue Common Stocks to Employees Under Share Compensation Plan
22/06DAIICHI SANKYO : Corporate Governance Report
15/06Japan's Daiichi Sankyo halts trials of existing drug for COVID-19 treatment
14/06BOURSE DE TOKYO : Borsa Tokyo in rialzo, Toshiba avanza dopo estromissione dirigenti board
14/06Japanese shares inch higher, Toshiba up after ouster of board directors
14/06Japanese shares track Wall Street higher, gains capped as investors await Fed's stateme..
11/06Daiichi Sankyo Company, Limited Announces New Data for valemetostat
11/06Daiichi Sankyo Announces That Delytact® Oncolytic Virus G47 Approves in Japan for Treat..
08/06Nikkei 225 Slips 0.2% on Inflation Outlook, Asian Market Softness
08/06Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
1  2  3  4  5  6  7  8  9  10Suiv.